Nutriband Inc. Reports Revenue Up 56% in Fiscal 2022 to a Record $1.4M
- Friday, April 29, 2022, 7:04
- Finance
- Add a comment
ORLANDO, Fla., April 29, 2022 /PRNewswire/ — Nutriband Inc. (NASDAQ: NTRB), a developer of transdermal pharmaceutical products, today announced financial and operational results for the fiscal year ended January 31, 2022. Key Highlights: Generated record revenue of $1.4 million, up 56%…
About the Author
adminasapcorp has written 39579 stories on this site.